Intravitreal bevacizumab treatment of macular edema due to optic disc vasculitis.
To report the efficacy of intravitreal bevacizumab injection in treatment of macular edema in a case of optic disc vasculitis. Retrospective case review. A patient diagnosed with macular edema due to optic disc vasculitis was treated with intravitreal bevacizumab injection. One week after injection, fundus appearance dramatically improved and macular edema regressed. The patient was followed up for 1 year after injection and there was no recurrence of macular edema. This case suggests that intravitreal bevacizumab treatment might be effective in the management of macular edema in patients with optic disc vasculitis.